SEATTLE — Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases (NIAID). This funding will fuel the commercialization of a first-in-class solution for the discovery of DNA viruses, employing a novel reagent kit and […]
Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market. The funding comes from two existing backers. Mercia has invested from its Northern Venture Capital Trust (VCT) and EIS funds and the North East Venture Fund (NEVF), which is […]
WOBURN, Mass. — ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by Sequoia Capital China and healthcare-focused investor LYFE Capital. Other new and existing shareholders, such as Sigma Square Capital, Kinghall Ventures, and Lucion Capital, participated in the new round. ABclonal Biotechnology, parent company of Massachusetts-based life […]
Orders for the company’s AQS3pro™ platform grew over 500% in the second full year since product launch, and the company closed a $6.4 million Series D Preferred Stock extension to support continued aggressive growth in 2021. Burlington, MA – February 18th, 2021 RedShift BioAnalytics, Inc. (www.redshiftbio.com), a provider of innovative analytical solutions for protein characterization used […]
HighCape Capital Acquisition Corporation The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP. The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, […]
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced it has raised significant investment from Kester Capital, a leading UK mid-market private equity firm typically investing between £10 to […]
Investment to expand Scitara Digital Lab Exchange (DLX) platform capabilities aimed at digitalizing laboratory data, establishing strategic partnerships, and fulfilling customer demand Marlborough, MA: Scitara Corporation, a global provider of laboratory-specific, cloud-based software solutions for the biopharmaceutical and industrial markets, today announced the closing of $5 million in a Series A round. The investment was led by Northpond […]
The funding is led by VisVires New Protein (Singapore), with EIT Food (Belgium) joining the round Renens (VD) – Swiss biotech company SwissDeCode has closed its first venture round, raising CHF 3.7M from VisVires New Protein (VVNP) and EIT Food (Europe’s leading food innovation initiative). The new funding comes after a recent award of €2.5M […]
Encodia is developing revolutionary tools for large-scale protein analysis to enable breakthrough insights into biology and the prevention, diagnosis, and treatment of disease SAN DIEGO, Calif.: Encodia, a privately-held biotech company developing next-generation solutions for proteomics research, announced the closing of a $75 million Series C financing led by Northpond Ventures and Deerfield Management, joined by GV, Alexandria Venture Investments, […]
As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Seattle, WA: Split Biosciences, a company providing researchers scalable and flexible single cell sequencing solutions, today announced $7M in Series A funding. The funding round was led […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
